中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [40]
采集方式
OAI收割 [40]
内容类型
期刊论文 [40]
发表日期
2024 [1]
2023 [2]
2022 [3]
2021 [10]
2019 [2]
2018 [6]
更多
学科主题
筛选
浏览/检索结果:
共40条,第1-10条
帮助
限定条件
专题:上海药物研究所
第一署名单位
第一作者单位
通讯作者单位
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
MATLAB language assisted data acquisition and processing in liquid chromatography Orbitrap mass spectrometry: Application to the identification and differentiation of Radix Bupleuri from its adulterants
期刊论文
OAI收割
JOURNAL OF CHROMATOGRAPHY A, 2024, 卷号: 1714, 页码: 10
作者:
Shen, Xuan-jing
;
Zhang, Jian-qing
;
An, Ya-ling
;
Yang, Lin
;
Li, Xiao-lan
  |  
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2024/02/27
Radix Bupleuri
Adulterants
MATLAB
precursor ion list (PIL)
identification
Single-cell RNA sequencing reveals the suppressive effect of PPP1R15A inhibitor Sephin1 in antitumor immunity
期刊论文
OAI收割
ISCIENCE, 2023, 卷号: 26, 期号: 2, 页码: 27
作者:
Wang, Rongjing
;
Zhang, Yuchao
;
Guo, Shiwei
;
Pei, Siyu
;
Guo, Wei
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2023/10/17
Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster
期刊论文
OAI收割
ANTIVIRAL RESEARCH, 2023, 卷号: 209, 页码: 9
作者:
Zhang, Ya-Nan
;
Zhang, Hong-Qing
;
Wang, Gui-Feng
;
Zhang, Zhe-Rui
;
Li, Jia-Qi
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2023/04/10
Omicron
VEEV VRP
Replicable mRNA
Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia
期刊论文
OAI收割
CELL RESEARCH, 2022, 页码: 19
作者:
Hu, Cheng-Long
;
Chen, Bing-Yi
;
Li, Zijuan
;
Yang, Tianbiao
;
Xu, Chun-Hui
  |  
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2022/12/13
Absorption, distribution, metabolism, and excretion of [C-14]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats
期刊论文
OAI收割
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 页码: 12
作者:
Li, Xin-mei
;
Zheng, Yuan-dong
;
Zhang, Yi-fan
;
Huan, Xia-juan
;
Yang, Chen
  |  
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2022/12/13
[C-14]Mefuparib
Mefuparib (CVL218)
Blood-brain barrier
Mass balance
Tissue distribution
GastroPlus simulation
Novel assays for quality evaluation of XueBiJing: Quality variability of a Chinese herbal injection for sepsis management
期刊论文
OAI收割
JOURNAL OF PHARMACEUTICAL ANALYSIS, 2022, 卷号: 12, 期号: 4, 页码: 664-682
作者:
Yu, Xuan
;
Niu, Wei
;
Wang, Ya-Ya
;
Olaleye, Olajide E.
;
Wang, Jia-Nan
  |  
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2022/11/11
XueBiJing
Chinese herbal medicine
Quality variability
Quality marker
One -point calibration
Graphene nanoribbon-based supramolecular ensembles with dual-receptor targeting function for targeted photothermal tumor therapy
期刊论文
OAI收割
CHEMICAL SCIENCE, 2021, 页码: 9
作者:
Dou, Wei-Tao
;
Xu, Fugui
;
Xu, Chen-Xi
;
Gao, Jie
;
Ru, Hong-Bo
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2021/08/17
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
期刊论文
OAI收割
CELL RESEARCH, 2021, 页码: 14
作者:
Xia, Bingqing
;
Shen, Xurui
;
He, Yang
;
Pan, Xiaoyan
;
Liu, Feng-Liang
  |  
收藏
  |  
浏览/下载:74/0
  |  
提交时间:2021/08/17
Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2021, 页码: 18
作者:
Lan, Xiao-fang
;
Olaleye, Olajide E.
;
Lu, Jun-lan
;
Yang, Wei
;
Du, Fei-fei
  |  
收藏
  |  
浏览/下载:47/0
  |  
提交时间:2021/06/11
LianhuaQingwen
glycyrrhetic acid
24-hydroxyglycyrrhetic acid
Gancao-induced pseudoaldosteronism
licorice-induced pseudoaldosteronism
11β
-hydroxysteroid dehydrogenase 2
COVID-19
colonic microbiota
Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial
期刊论文
OAI收割
FRONTIERS OF MEDICINE, 2021, 页码: 14
作者:
Ni, Li
;
Wen, Zheng
;
Hu, Xiaowen
;
Tang, Wei
;
Wang, Haisheng
  |  
收藏
  |  
浏览/下载:50/0
  |  
提交时间:2021/08/17
COVID-19
SARS-CoV-2
Shuanghuanglian oral liquid
clinical trial